Liraglutide East Asian Dose Adjustments: What the Evidence Actually Shows
The Saxenda and Victoza labels give one titration schedule and no East Asian adjustment. A 14-week Japanese trial tested 0.1 to 0.9 mg daily.
4 source-based articles maintained by the HealthRX.com Editorial Team.
Showing 4 of 4 clinical reviews.
The Saxenda and Victoza labels give one titration schedule and no East Asian adjustment. A 14-week Japanese trial tested 0.1 to 0.9 mg daily.
Evidence-based review of liraglutide response differences in Black and African ancestry populations, including ethnicity-stratified trial data, pharmacogenomic factors, and clinical dosing guidance.
Evidence-based review of how liraglutide safety, pharmacogenomics, and dosing considerations differ for Hispanic and Latino populations, with ethnicity-stratified trial data and clinical guidance.
A guide to liraglutide dosing considerations for South Asian patients, covering ethnicity-adjusted BMI thresholds, cardiovascular risk context, pharmacokinetic reasoning, and where the evidence runs out.